{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Showing 1 - 3 of 3 results
Status:
Investigational
Source:
NCT01037231: Phase 2/Phase 3 Interventional Completed Primary Hyperoxaluria
(2009)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Designated
Source:
FDA ORPHAN DRUG:219206
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE